BIOMAT Database Logo BIOMAT Database Logo

[Treatment of overweight diabetics with a combination of glibenclamide and phenformin]. 1977

G Palmieri, and M Alkabes

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Palmieri, and M Alkabes
[Glibenclamide-phenformin in diabetics with failures after sulfonylureas].
December 1971, La Prensa medica mexicana,
G Palmieri, and M Alkabes
[Glibenclamide-phenformin combination in the treatment of diabetes in adults].
August 1975, La Clinica terapeutica,
G Palmieri, and M Alkabes
[Modifications induced in post-prandial glycemia and insulinemia by treatment with glibenclamide and with a combination of glibenclamide and phenformin].
May 1974, Il Farmaco; edizione pratica,
G Palmieri, and M Alkabes
Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
June 1971, Israel journal of medical sciences,
G Palmieri, and M Alkabes
[Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
September 1974, Minerva medica,
G Palmieri, and M Alkabes
[The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
August 1974, Minerva medica,
G Palmieri, and M Alkabes
[The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
July 1974, La Clinica terapeutica,
G Palmieri, and M Alkabes
Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.
April 1977, Diabetologia,
G Palmieri, and M Alkabes
[Treatment of obese diabetics with phenformin HCl (Dibein)].
February 1966, Ugeskrift for laeger,
G Palmieri, and M Alkabes
[Metabolic control and insulin secretion in diabetic patients treated with glibenclamide-phenformin combination].
November 1975, La Clinica terapeutica,
Copied contents to your clipboard!